메뉴 건너뛰기




Volumn 23, Issue 10, 2006, Pages 781-793

Post-transplant diabetes mellitus: Risk reduction strategies in the elderly

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

EID: 33750500310     PISSN: 1170229X     EISSN: 1170229X     Source Type: Journal    
DOI: 10.2165/00002512-200623100-00002     Document Type: Review
Times cited : (10)

References (106)
  • 1
    • 0036379686 scopus 로고    scopus 로고
    • Patient survival after renal transplantation: IV. Impact of post-transplant diabetes
    • Cosio FG, Pesavento TE, Kim S, et al. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int 2002; 62: 1440-6
    • (2002) Kidney Int , vol.62 , pp. 1440-1446
    • Cosio, F.G.1    Pesavento, T.E.2    Kim, S.3
  • 2
    • 0035095701 scopus 로고    scopus 로고
    • Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation
    • Revanur VK, Jardine AG, Kingsmore DB, et al. Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation. Clin Transplant 2001; 15: 89-94
    • (2001) Clin Transplant , vol.15 , pp. 89-94
    • Revanur, V.K.1    Jardine, A.G.2    Kingsmore, D.B.3
  • 3
    • 0345870154 scopus 로고    scopus 로고
    • Development of diabetes mellitus post-renal transplantation is associated with poor short-term clinical outcomes
    • Saleem TF, Cunningham KE, Hollenbeak CS, et al. Development of diabetes mellitus post-renal transplantation is associated with poor short-term clinical outcomes. Transplant Proc 2003; 35: 2916-8
    • (2003) Transplant Proc , vol.35 , pp. 2916-2918
    • Saleem, T.F.1    Cunningham, K.E.2    Hollenbeak, C.S.3
  • 4
    • 21244451586 scopus 로고    scopus 로고
    • Random blood glucose measurements and survival in nondiabetic renal transplant recipients
    • Tutone VK, Mark PB, Revanur V, et al. Random blood glucose measurements and survival in nondiabetic renal transplant recipients. Transplant Proc 2004; 36: 3006-11
    • (2004) Transplant Proc , vol.36 , pp. 3006-3011
    • Tutone, V.K.1    Mark, P.B.2    Revanur, V.3
  • 5
    • 0035722250 scopus 로고    scopus 로고
    • Risk factors for post-transplant tuberculosis
    • John GT, Shankar V, Abraham AM, et al. Risk factors for post-transplant tuberculosis. Kidney Int 2001; 60: 1148-53
    • (2001) Kidney Int , vol.60 , pp. 1148-1153
    • John, G.T.1    Shankar, V.2    Abraham, A.M.3
  • 6
    • 0037910288 scopus 로고    scopus 로고
    • Epidemiology of systemic mycoses among renal-transplant recipients in India
    • Tharayil JG, Shankar V, Talaulikar G, et al. Epidemiology of systemic mycoses among renal-transplant recipients in India. Transplantation 2003; 75: 1544-51
    • (2003) Transplantation , vol.75 , pp. 1544-1551
    • Tharayil, J.G.1    Shankar, V.2    Talaulikar, G.3
  • 7
    • 29544441578 scopus 로고    scopus 로고
    • Cardiovascular risk factors in diabetic patients with renal transplants
    • Diaz JM, Sainz Z, Gich I, et al. Cardiovascular risk factors in diabetic patients with renal transplants. Transplant Proc 2005; 37: 3802-4
    • (2005) Transplant Proc , vol.37 , pp. 3802-3804
    • Diaz, J.M.1    Sainz, Z.2    Gich, I.3
  • 8
    • 23044499556 scopus 로고    scopus 로고
    • New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation
    • Cosio FG, Kudva Y, van der Velde M, et al. New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int 2005; 67: 2415-21
    • (2005) Kidney Int , vol.67 , pp. 2415-2421
    • Cosio, F.G.1    Kudva, Y.2    Van Der Velde, M.3
  • 9
    • 14044273016 scopus 로고    scopus 로고
    • Posttransplant diabetes mellitus and atherosclerotic events in renal transplant recipients: A prospective study
    • Ducloux D, Kazory A, Chalopin JM. Posttransplant diabetes mellitus and atherosclerotic events in renal transplant recipients: a prospective study. Transplantation 2005; 79: 438-43
    • (2005) Transplantation , vol.79 , pp. 438-443
    • Ducloux, D.1    Kazory, A.2    Chalopin, J.M.3
  • 10
    • 33750518900 scopus 로고    scopus 로고
    • [online]. Available from URL: [Accessed 2006 Jun]
    • The Organ Procurement and Transplantation Network [online]. Available from URL: http://www.optn.org/Data/rptData.asp [Accessed 2006 Jun]
  • 11
    • 33846853461 scopus 로고    scopus 로고
    • Clinical practice recommendations
    • American Diabetes Association
    • American Diabetes Association. Clinical practice recommendations. Diabetes Care 2006; 29 Suppl.: S43-8
    • (2006) Diabetes Care , vol.29 , Issue.SUPPL.
  • 12
    • 26644438094 scopus 로고    scopus 로고
    • Home glucometer monitoring markedly improves diagnosis of post renal transplant diabetes mellitus in renal transplant recipients
    • Shah A, Kendall G, Demme RA, et al. Home glucometer monitoring markedly improves diagnosis of post renal transplant diabetes mellitus in renal transplant recipients. Transplantation 2005; 80: 775-81
    • (2005) Transplantation , vol.80 , pp. 775-781
    • Shah, A.1    Kendall, G.2    Demme, R.A.3
  • 13
    • 0031752685 scopus 로고    scopus 로고
    • Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections
    • King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-31
    • (1998) Diabetes Care , vol.21 , pp. 1414-1431
    • King, H.1    Aubert, R.E.2    Herman, W.H.3
  • 14
    • 2342466734 scopus 로고    scopus 로고
    • Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030
    • Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-53
    • (2004) Diabetes Care , vol.27 , pp. 1047-1053
    • Wild, S.1    Roglic, G.2    Green, A.3
  • 15
    • 0035850402 scopus 로고    scopus 로고
    • The continuing epidemics of obesity and diabetes in the United States
    • Mokdad AH, Bowman BA, Ford ES, et al. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001; 286: 1195-200
    • (2001) JAMA , vol.286 , pp. 1195-1200
    • Mokdad, A.H.1    Bowman, B.A.2    Ford, E.S.3
  • 16
    • 0035126824 scopus 로고    scopus 로고
    • Influence of tacrolimus on glucose metabolism before and after renal transplantation: A prospective study
    • Duijnhoven EM, Boots JM, Christiaans MH, et al. Influence of tacrolimus on glucose metabolism before and after renal transplantation: a prospective study. J Am Soc Nephrol 2001; 12: 583-8
    • (2001) J Am Soc Nephrol , vol.12 , pp. 583-588
    • Duijnhoven, E.M.1    Boots, J.M.2    Christiaans, M.H.3
  • 17
    • 0035958103 scopus 로고    scopus 로고
    • Beta-cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitus
    • Nam JH, Mun JI, Kim SI, et al. Beta-cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitus. Transplantation 2001; 71: 1417-23
    • (2001) Transplantation , vol.71 , pp. 1417-1423
    • Nam, J.H.1    Mun, J.I.2    Kim, S.I.3
  • 18
    • 10744233539 scopus 로고    scopus 로고
    • Diabetes mellitus after transplant: Relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy
    • Sato T, Inagaki A, Uchida K, et al. Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy. Transplantation 2003; 76: 1320-6
    • (2003) Transplantation , vol.76 , pp. 1320-1326
    • Sato, T.1    Inagaki, A.2    Uchida, K.3
  • 19
    • 0018420446 scopus 로고
    • Diabetes mellitus: A more-common-than-believed complication of renal transplantation
    • Gunnarsson R, Arner P, Lundgren G, et al. Diabetes mellitus: a more-common-than-believed complication of renal transplantation. Transplant Proc 1979; 11: 1280-1
    • (1979) Transplant Proc , vol.11 , pp. 1280-1281
    • Gunnarsson, R.1    Arner, P.2    Lundgren, G.3
  • 20
    • 0026092365 scopus 로고
    • Diabetes mellitus after renal transplantation in the cyclosporine era: An analysis of risk factors
    • Sumrani NB, Delaney V, Ding ZK, et al. Diabetes mellitus after renal transplantation in the cyclosporine era: an analysis of risk factors. Transplantation 1991; 51: 343-7
    • (1991) Transplantation , vol.51 , pp. 343-347
    • Sumrani, N.B.1    Delaney, V.2    Ding, Z.K.3
  • 21
    • 0035132552 scopus 로고    scopus 로고
    • Post-transplant diabetes mellitus: Increasing incidence in renal allograft recipients transplanted in recent years
    • Cosio FG, Pesavento TE, Osei K, et al. Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int 2001; 59: 732-7
    • (2001) Kidney Int , vol.59 , pp. 732-737
    • Cosio, F.G.1    Pesavento, T.E.2    Osei, K.3
  • 22
    • 0037297155 scopus 로고    scopus 로고
    • Diabetes mellitus after kidney transplantation in the United States
    • Kasiske BL, Snyder JJ, Gilbertson D, et al. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003; 3: 178-85
    • (2003) Am J Transplant , vol.3 , pp. 178-185
    • Kasiske, B.L.1    Snyder, J.J.2    Gilbertson, D.3
  • 23
    • 0016756788 scopus 로고
    • Hyperosmolar nonketotic syndrome and steroid diabetes: Occurrence after renal transplantation
    • Woods JE, Zincke H, Palumbo PJ, et al. Hyperosmolar nonketotic syndrome and steroid diabetes: occurrence after renal transplantation. JAMA 1975; 231: 1261-3
    • (1975) JAMA , vol.231 , pp. 1261-1263
    • Woods, J.E.1    Zincke, H.2    Palumbo, P.J.3
  • 24
    • 84943430958 scopus 로고
    • HLA-A28 and steroid-induced diabetes in renal transplant patients
    • David DS, Cheigh JS, Braun Jr DW, et al. HLA-A28 and steroid-induced diabetes in renal transplant patients. JAMA 1980; 243: 532-3
    • (1980) JAMA , vol.243 , pp. 532-533
    • David, D.S.1    Cheigh, J.S.2    Braun Jr., D.W.3
  • 25
    • 32844474104 scopus 로고    scopus 로고
    • Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin or mTOR inhibitor drugs
    • Araki M, Flechner SM, Ismail HR, et al. Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin or mTOR inhibitor drugs. Transplantation 2006; 81: 335-41
    • (2006) Transplantation , vol.81 , pp. 335-341
    • Araki, M.1    Flechner, S.M.2    Ismail, H.R.3
  • 26
    • 0023230559 scopus 로고
    • The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients
    • Boudreaux JP, McHugh L, Canafax DM, et al. The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplantation 1987; 44: 376-81
    • (1987) Transplantation , vol.44 , pp. 376-381
    • Boudreaux, J.P.1    McHugh, L.2    Canafax, D.M.3
  • 27
    • 0033610677 scopus 로고    scopus 로고
    • The effects of maintenance doses of FK506 versus cyclosporin A on glucose and lipid metabolism after orthotopic liver transplantation
    • Fernandez LA, Lehmann R, Luzi L, et al. The effects of maintenance doses of FK506 versus cyclosporin A on glucose and lipid metabolism after orthotopic liver transplantation. Transplantation 1999; 68: 1532-41
    • (1999) Transplantation , vol.68 , pp. 1532-1541
    • Fernandez, L.A.1    Lehmann, R.2    Luzi, L.3
  • 28
    • 0036310155 scopus 로고    scopus 로고
    • NFAT regulates insulin gene promoter activity in response to synergistic pathways induced by glucose and glucagon-like peptide-1
    • Lawrence MC, Bhatt HS, Easom RA. NFAT regulates insulin gene promoter activity in response to synergistic pathways induced by glucose and glucagon-like peptide-1. Diabetes 2002; 51: 691-8
    • (2002) Diabetes , vol.51 , pp. 691-698
    • Lawrence, M.C.1    Bhatt, H.S.2    Easom, R.A.3
  • 29
    • 0034796114 scopus 로고    scopus 로고
    • Regulation of insulin gene transcription by a Ca(2+)-responsive pathway involving calcineurin and nuclear factor of activated T cells
    • Lawrence MC, Bhatt HS, Watterson JM, et al. Regulation of insulin gene transcription by a Ca(2+)-responsive pathway involving calcineurin and nuclear factor of activated T cells. Mol Endocrinol 2001; 15: 1758-67
    • (2001) Mol Endocrinol , vol.15 , pp. 1758-1767
    • Lawrence, M.C.1    Bhatt, H.S.2    Watterson, J.M.3
  • 30
    • 0028168125 scopus 로고
    • Interaction of tacrolimus (FK506) and its metabolites with FKBP and calcineurin
    • Tamura K, Fujimura T, Iwasaki K, et al. Interaction of tacrolimus (FK506) and its metabolites with FKBP and calcineurin. Biochem Biophys Res Commun 1994; 202: 437-43
    • (1994) Biochem Biophys Res Commun , vol.202 , pp. 437-443
    • Tamura, K.1    Fujimura, T.2    Iwasaki, K.3
  • 31
    • 0029056853 scopus 로고
    • Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic beta-cell
    • Tamura K, Fujimura T, Tsutsumi T, et al. Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic beta-cell. Transplantation 1995; 59: 1606-13
    • (1995) Transplantation , vol.59 , pp. 1606-1613
    • Tamura, K.1    Fujimura, T.2    Tsutsumi, T.3
  • 32
    • 0030474003 scopus 로고    scopus 로고
    • Mechanisms of inhibition of insulin release
    • Sharp GW. Mechanisms of inhibition of insulin release. Am J Physiol 1996; 271 (Pt 1): C1781-99
    • (1996) Am J Physiol , vol.271 , Issue.PART 1
    • Sharp, G.W.1
  • 33
    • 0032541081 scopus 로고    scopus 로고
    • Gene-specific transcriptional activity of the insulin cAMP-responsive element is conferred by NF-Y in combination with cAMP response element-binding protein
    • Eggers A, Siemann G, Blume R, et al. Gene-specific transcriptional activity of the insulin cAMP-responsive element is conferred by NF-Y in combination with cAMP response element-binding protein. J Biol Chem 1998; 273: 18499-508
    • (1998) J Biol Chem , vol.273 , pp. 18499-18508
    • Eggers, A.1    Siemann, G.2    Blume, R.3
  • 34
    • 0032976902 scopus 로고    scopus 로고
    • Inhibition of cyclic AMP response element-binding protein/cyclic AMP response element-mediated transcription by the immunosuppressive drugs cyclosporin A and FK506 depends on the promoter context
    • Siemann G, Blume R, Grapentin D, et al. Inhibition of cyclic AMP response element-binding protein/cyclic AMP response element-mediated transcription by the immunosuppressive drugs cyclosporin A and FK506 depends on the promoter context. Mol Pharmacol 1999; 55: 1094-100
    • (1999) Mol Pharmacol , vol.55 , pp. 1094-1100
    • Siemann, G.1    Blume, R.2    Grapentin, D.3
  • 35
    • 0038339191 scopus 로고    scopus 로고
    • cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2
    • Jhala US, Canettieri G, Screaton RA, et al. cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2. Genes Dev 2003; 17: 1575-80
    • (2003) Genes Dev , vol.17 , pp. 1575-1580
    • Jhala, U.S.1    Canettieri, G.2    Screaton, R.A.3
  • 36
    • 0029774262 scopus 로고    scopus 로고
    • Impaired cAMP-mediated gene expression and decreased cAMP response element binding protein in senescent cells
    • Chin JH, Okazaki N, Frazier JS, et al. Impaired cAMP-mediated gene expression and decreased cAMP response element binding protein in senescent cells. Am J Physiol 1996; 27: C362-71
    • (1996) Am J Physiol , vol.27
    • Chin, J.H.1    Okazaki, N.2    Frazier, J.S.3
  • 37
    • 33646873040 scopus 로고    scopus 로고
    • Downstream molecular events in the altered profiles of lysophosphatidic acid-induced cAMP in senescent human diploid fibroblasts
    • Jang IS, Rhim JH, Park S, et al. Downstream molecular events in the altered profiles of lysophosphatidic acid-induced cAMP in senescent human diploid fibroblasts. Exp Mol Med 2006; 38: 134-43
    • (2006) Exp Mol Med , vol.38 , pp. 134-143
    • Jang, I.S.1    Rhim, J.H.2    Park, S.3
  • 38
    • 0025946452 scopus 로고
    • Mechanisms of action of cyclosporin A on islet alpha- and beta-cells: Effects on cAMP- and calcium-dependent pathways
    • Martin F, Bedoya FJ. Mechanisms of action of cyclosporin A on islet alpha- and beta-cells: effects on cAMP- and calcium-dependent pathways. Life Sci 1991; 49: 1915-21
    • (1991) Life Sci , vol.49 , pp. 1915-1921
    • Martin, F.1    Bedoya, F.J.2
  • 39
    • 1942502245 scopus 로고    scopus 로고
    • New onset diabetes mellitus in patients receiving calcineurin inhibitors: A systematic review and metaanalysis
    • Heisel O, Heisel R, Balshaw R, et al. New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and metaanalysis. Am J Transplant 2004; 4: 583-95
    • (2004) Am J Transplant , vol.4 , pp. 583-595
    • Heisel, O.1    Heisel, R.2    Balshaw, R.3
  • 40
    • 0037006627 scopus 로고    scopus 로고
    • Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in renal transplantation: A randomized multicenter study
    • Margreiter R. Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in renal transplantation: a randomized multicenter study. Lancet 2002; 359: 741-6
    • (2002) Lancet , vol.359 , pp. 741-746
    • Margreiter, R.1
  • 41
    • 0036139867 scopus 로고    scopus 로고
    • Glucose metabolism in the first 3 years after renal transplantation in patients receiving tacrolimus versus cyclosporine-based immuno-suppression
    • van Duijnhoven EM, Christiaans MH, Boots JM, et al. Glucose metabolism in the first 3 years after renal transplantation in patients receiving tacrolimus versus cyclosporine-based immuno-suppression. J Am Soc Nephrol 2002; 13: 213-20
    • (2002) J Am Soc Nephrol , vol.13 , pp. 213-220
    • Van Duijnhoven, E.M.1    Christiaans, M.H.2    Boots, J.M.3
  • 42
    • 0141595345 scopus 로고    scopus 로고
    • Ethnic disparities in type 2 diabetes: Pathophysiology and implications for prevention and management
    • Dagogo-Jack S. Ethnic disparities in type 2 diabetes: pathophysiology and implications for prevention and management. J Natl Med Assoc 2003; 95: 779-89
    • (2003) J Natl Med Assoc , vol.95 , pp. 779-789
    • Dagogo-Jack, S.1
  • 43
    • 0037183179 scopus 로고    scopus 로고
    • Outcomes of African American kidney transplant recipients treated with sirolimus, tacrolimus, and corticosteroids
    • Hricik DE, Anton HA, Knauss TC, et al. Outcomes of African American kidney transplant recipients treated with sirolimus, tacrolimus, and corticosteroids. Transplantation 2002; 74: 189-93
    • (2002) Transplantation , vol.74 , pp. 189-193
    • Hricik, D.E.1    Anton, H.A.2    Knauss, T.C.3
  • 44
    • 22244452014 scopus 로고    scopus 로고
    • Increased risk of post-transplant diabetes mellitus despite early steroid discontinuation in Hispanic kidney transplant recipients
    • Walczak DA, Calvert D, Jarzembowski TM, et al. Increased risk of post-transplant diabetes mellitus despite early steroid discontinuation in Hispanic kidney transplant recipients. Clin Transplant 2005; 19: 527-31
    • (2005) Clin Transplant , vol.19 , pp. 527-531
    • Walczak, D.A.1    Calvert, D.2    Jarzembowski, T.M.3
  • 45
    • 0036012951 scopus 로고    scopus 로고
    • Metabolic differences between Caucasian and African-American children and the relationship to type 2 diabetes mellitus
    • Arslanian SA. Metabolic differences between Caucasian and African-American children and the relationship to type 2 diabetes mellitus. J Pediatr Endocrinol 2002; 15 Suppl. 1: 509-17
    • (2002) J Pediatr Endocrinol , vol.15 , Issue.SUPPL. 1 , pp. 509-517
    • Arslanian, S.A.1
  • 46
    • 0036012944 scopus 로고    scopus 로고
    • Impaired beta-cell and alpha-cell function in African-American children with type 2 diabetes mellitus: Flatbush diabetes
    • Banerji MA. Impaired beta-cell and alpha-cell function in African-American children with type 2 diabetes mellitus: flatbush diabetes. J Pediatr Endocrinol 2002; 15 Suppl. 1: 493-501
    • (2002) J Pediatr Endocrinol , vol.15 , Issue.SUPPL. 1 , pp. 493-501
    • Banerji, M.A.1
  • 47
    • 7244226498 scopus 로고    scopus 로고
    • Development of diabetes mellitus following kidney transplantation: A Canadian experience
    • Gourishankar S, Jhangri GS, Tonelli M, et al. Development of diabetes mellitus following kidney transplantation: a Canadian experience. Am J Transplant 2004; 4: 1876-82
    • (2004) Am J Transplant , vol.4 , pp. 1876-1882
    • Gourishankar, S.1    Jhangri, G.S.2    Tonelli, M.3
  • 48
    • 3242697089 scopus 로고    scopus 로고
    • Impact of diabetes mellitus on kidney transplant recipients in Spain
    • Gonzalez-Posada JM, Hernandez D, Bayes Genis B, et al. Impact of diabetes mellitus on kidney transplant recipients in Spain. Nephrol Dial Transplant 2004; 19 Suppl. 3: iii57-61
    • (2004) Nephrol Dial Transplant , vol.19 , Issue.SUPPL. 3
    • Gonzalez-Posada, J.M.1    Hernandez, D.2    Bayes Genis, B.3
  • 49
    • 29544442822 scopus 로고    scopus 로고
    • Posttransplantation diabetes mellitus: Prevalence and risk factors
    • Baltar J, Ortega T, Ortega F, et al. Posttransplantation diabetes mellitus: prevalence and risk factors. Transplant Proc 2005; 37: 3817-8
    • (2005) Transplant Proc , vol.37 , pp. 3817-3818
    • Baltar, J.1    Ortega, T.2    Ortega, F.3
  • 50
    • 29144458884 scopus 로고    scopus 로고
    • Clinical and genetic risk factors for posttransplant diabetes mellitus in adult renal transplant recipients treated with tacrolimus
    • Numakura K, Satoh S, Tsuchiya N, et al. Clinical and genetic risk factors for posttransplant diabetes mellitus in adult renal transplant recipients treated with tacrolimus. Transplantation 2005; 80: 1419-24
    • (2005) Transplantation , vol.80 , pp. 1419-1424
    • Numakura, K.1    Satoh, S.2    Tsuchiya, N.3
  • 51
    • 20344401339 scopus 로고    scopus 로고
    • Factors influencing the onset of diabetes mellitus after kidney transplantation: A single French center experience
    • Marin M, Renoult E, Bondor CI, et al. Factors influencing the onset of diabetes mellitus after kidney transplantation: a single French center experience. Transplant Proc 2005; 37: 1851-6
    • (2005) Transplant Proc , vol.37 , pp. 1851-1856
    • Marin, M.1    Renoult, E.2    Bondor, C.I.3
  • 52
    • 0042810786 scopus 로고    scopus 로고
    • Age and glucose intolerance: Effect of fitness and fatness
    • Reaven G. Age and glucose intolerance: effect of fitness and fatness. Diabetes Care 2003; 26: 539-40
    • (2003) Diabetes Care , vol.26 , pp. 539-540
    • Reaven, G.1
  • 53
    • 0030045106 scopus 로고    scopus 로고
    • Age-related alteration of pancreatic beta-cell function: Increased proinsulin and proinsulin-to-insulin molar ratio in elderly, but not in obese, subjects without glucose intolerance
    • Shimizu M, Kawazu S, Tomono S, et al. Age-related alteration of pancreatic beta-cell function: increased proinsulin and proinsulin-to-insulin molar ratio in elderly, but not in obese, subjects without glucose intolerance. Diabetes Care 1996; 19: 8-11
    • (1996) Diabetes Care , vol.19 , pp. 8-11
    • Shimizu, M.1    Kawazu, S.2    Tomono, S.3
  • 54
    • 0042810827 scopus 로고    scopus 로고
    • Aging per se does not influence glucose homeostasis: In vivo and in vitro evidence
    • Imbeault P, Prins JB, Stolic M, et al. Aging per se does not influence glucose homeostasis: in vivo and in vitro evidence. Diabetes Care 2003; 26: 480-4
    • (2003) Diabetes Care , vol.26 , pp. 480-484
    • Imbeault, P.1    Prins, J.B.2    Stolic, M.3
  • 55
    • 4344581405 scopus 로고    scopus 로고
    • Disruption of the SH2-B gene causes age-dependent insulin resistance and glucose intolerance
    • Duan C, Yang H, White MF, et al. Disruption of the SH2-B gene causes age-dependent insulin resistance and glucose intolerance. Mol Cell Biol 2004; 24: 7435-43
    • (2004) Mol Cell Biol , vol.24 , pp. 7435-7443
    • Duan, C.1    Yang, H.2    White, M.F.3
  • 56
    • 0037231817 scopus 로고    scopus 로고
    • Post-transplant hyperglycemia: A study of risk factors
    • Mathew JT, Rao M, Job V, et al. Post-transplant hyperglycemia: a study of risk factors. Nephrol Dial Transplant 2003; 18: 164-71
    • (2003) Nephrol Dial Transplant , vol.18 , pp. 164-171
    • Mathew, J.T.1    Rao, M.2    Job, V.3
  • 57
    • 5444245634 scopus 로고    scopus 로고
    • Hepatitis C virus-associated extrahepatic manifestations: A review
    • Sene D, Limal N, Cacoub P. Hepatitis C virus-associated extrahepatic manifestations: a review. Metab Brain Dis 2004; 19: 357-81
    • (2004) Metab Brain Dis , vol.19 , pp. 357-381
    • Sene, D.1    Limal, N.2    Cacoub, P.3
  • 58
    • 3142590775 scopus 로고    scopus 로고
    • Association of diabetes and hepatitis C infection: Epidemiologic evidence and pathophysiologic insights
    • Bahtiyar G, Shin JJ, Aytaman A, et al. Association of diabetes and hepatitis C infection: epidemiologic evidence and pathophysiologic insights. Curr Diab Rep 2004; 4: 194-8
    • (2004) Curr Diab Rep , vol.4 , pp. 194-198
    • Bahtiyar, G.1    Shin, J.J.2    Aytaman, A.3
  • 59
    • 27644508836 scopus 로고    scopus 로고
    • Review article: An unexpected virus-host interaction: The hepatitis C virus-diabetes link
    • Ratziu V, Heurtier A, Bonyhay L, et al. Review article: an unexpected virus-host interaction: the hepatitis C virus-diabetes link. Aliment Pharmacol Ther 2005; 22 Suppl. 2: 56-60
    • (2005) Aliment Pharmacol Ther , vol.22 , Issue.SUPPL. 2 , pp. 56-60
    • Ratziu, V.1    Heurtier, A.2    Bonyhay, L.3
  • 60
    • 0030047625 scopus 로고    scopus 로고
    • Erythrocyte membrane fluidity in adult polycystic kidney disease: Difference between intact cells and ghost membranes
    • Vareesangthip K, Thomas TH, Tong P, et al. Erythrocyte membrane fluidity in adult polycystic kidney disease: difference between intact cells and ghost membranes. Eur J Clin Invest 1996; 26: 171-3
    • (1996) Eur J Clin Invest , vol.26 , pp. 171-173
    • Vareesangthip, K.1    Thomas, T.H.2    Tong, P.3
  • 61
    • 85047699165 scopus 로고
    • Abnormal effect of thiol groups on erythrocyte Na/Li counter transport kinetics in adult polycystic kidney disease
    • Vareesangthip K, Thomas TH, Wilkinson R. Abnormal effect of thiol groups on erythrocyte Na/Li counter transport kinetics in adult polycystic kidney disease. Nephrol Dial Transplant 1995; 10: 2219-23
    • (1995) Nephrol Dial Transplant , vol.10 , pp. 2219-2223
    • Vareesangthip, K.1    Thomas, T.H.2    Wilkinson, R.3
  • 62
    • 0030875694 scopus 로고    scopus 로고
    • Insulin resistance in adult polycystic kidney disease
    • Vareesangthip K, Tong P, Wilkinson R, et al. Insulin resistance in adult polycystic kidney disease. Kidney Int 1997; 52: 503-8
    • (1997) Kidney Int , vol.52 , pp. 503-508
    • Vareesangthip, K.1    Tong, P.2    Wilkinson, R.3
  • 63
    • 12344333418 scopus 로고    scopus 로고
    • Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation
    • de Mattos AM, Olyaei AJ, Prather JC, et al. Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation. Kidney Int 2005; 67: 714-20
    • (2005) Kidney Int , vol.67 , pp. 714-720
    • De Mattos, A.M.1    Olyaei, A.J.2    Prather, J.C.3
  • 64
    • 33645422488 scopus 로고    scopus 로고
    • Family history of type 2 diabetes: A population-based screening tool for prevention?
    • Hariri S, Yoon PW, Qureshi N, et al. Family history of type 2 diabetes: a population-based screening tool for prevention? Genet Med 2006; 8: 102-8
    • (2006) Genet Med , vol.8 , pp. 102-108
    • Hariri, S.1    Yoon, P.W.2    Qureshi, N.3
  • 65
    • 26444613340 scopus 로고    scopus 로고
    • Is HLA-DR6 a protective factor against posttransplantation diabetes mellitus?
    • Nafar M, Pour-Reza-Gholi F, Amouzegar A, et al. Is HLA-DR6 a protective factor against posttransplantation diabetes mellitus? Transplant Proc 2005; 37: 3098-100
    • (2005) Transplant Proc , vol.37 , pp. 3098-3100
    • Nafar, M.1    Pour-Reza-Gholi, F.2    Amouzegar, A.3
  • 66
    • 0033661749 scopus 로고    scopus 로고
    • Identification of glucokinase mutation in subjects with post-renal transplantation diabetes mellitus
    • Nam JH, Lee HC, Kim YH, et al. Identification of glucokinase mutation in subjects with post-renal transplantation diabetes mellitus. Diabet Res Clin Pract 2000; 50: 169-76
    • (2000) Diabet Res Clin Pract , vol.50 , pp. 169-176
    • Nam, J.H.1    Lee, H.C.2    Kim, Y.H.3
  • 67
    • 0347761625 scopus 로고    scopus 로고
    • Obesity as an independent predictor of posttransplant diabetes mellitus
    • Parikh CR, Klem P, Wong C, et al. Obesity as an independent predictor of posttransplant diabetes mellitus. Transplant Proc 2003; 35: 2922-6
    • (2003) Transplant Proc , vol.35 , pp. 2922-2926
    • Parikh, C.R.1    Klem, P.2    Wong, C.3
  • 68
    • 0033571518 scopus 로고    scopus 로고
    • Quantitative assessment of the first acute rejection as a predictor of renal transplant outcome
    • Ishikawa A, Flechner SM, Goldfarb DA, et al. Quantitative assessment of the first acute rejection as a predictor of renal transplant outcome. Transplantation 1999; 68: 1318-24
    • (1999) Transplantation , vol.68 , pp. 1318-1324
    • Ishikawa, A.1    Flechner, S.M.2    Goldfarb, D.A.3
  • 70
    • 4043137272 scopus 로고    scopus 로고
    • Prevalence and immunohistochemical findings of subclinical kidney allograft rejection and its association with graft outcome
    • Veronese FV, Noronha IL, Manfro RC, et al. Prevalence and immunohistochemical findings of subclinical kidney allograft rejection and its association with graft outcome. Clin Transplant 2004; 18: 357-64
    • (2004) Clin Transplant , vol.18 , pp. 357-364
    • Veronese, F.V.1    Noronha, I.L.2    Manfro, R.C.3
  • 71
    • 33644860184 scopus 로고    scopus 로고
    • Estimated one-year glomerular filtration rate is the best predictor of long-term graft function following renal transplant
    • Salvadori M, Rosati A, Bock A, et al. Estimated one-year glomerular filtration rate is the best predictor of long-term graft function following renal transplant. Transplantation 2006; 81: 202-6
    • (2006) Transplantation , vol.81 , pp. 202-206
    • Salvadori, M.1    Rosati, A.2    Bock, A.3
  • 72
    • 0030754436 scopus 로고    scopus 로고
    • Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age
    • Hjelmesaeth J, Hartmann A, Kofstad J, et al. Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation 1997; 64: 979-83
    • (1997) Transplantation , vol.64 , pp. 979-983
    • Hjelmesaeth, J.1    Hartmann, A.2    Kofstad, J.3
  • 73
    • 0036675855 scopus 로고    scopus 로고
    • Diabetes mellitus and hypertension: Key risk factors for kidney disease
    • Lea JP, Nicholas SB. Diabetes mellitus and hypertension: key risk factors for kidney disease. J Natl Med Assoc 2002; 94 Suppl. 8: 7S-15S
    • (2002) J Natl Med Assoc , vol.94 , Issue.SUPPL. 8
    • Lea, J.P.1    Nicholas, S.B.2
  • 74
    • 0034594631 scopus 로고    scopus 로고
    • Arterial hypertension and renal allograft survival
    • Mange KC, Cizman B, Joffe M, et al. Arterial hypertension and renal allograft survival. JAMA 2000; 283: 633-8
    • (2000) JAMA , vol.283 , pp. 633-638
    • Mange, K.C.1    Cizman, B.2    Joffe, M.3
  • 75
    • 2542464211 scopus 로고    scopus 로고
    • Hypertension after kidney transplantation
    • Kasiske BL, Anjum S, Shah R, et al. Hypertension after kidney transplantation. Am J Kidney Dis 2004; 43: 1071-81
    • (2004) Am J Kidney Dis , vol.43 , pp. 1071-1081
    • Kasiske, B.L.1    Anjum, S.2    Shah, R.3
  • 76
    • 15844420109 scopus 로고    scopus 로고
    • Hypertension, antihypertensive agents and outcomes following renal transplantation
    • Tutone VK, Mark PB, Stewart GA, et al. Hypertension, antihypertensive agents and outcomes following renal transplantation. Clin Transplant 2005; 19: 181-92
    • (2005) Clin Transplant , vol.19 , pp. 181-192
    • Tutone, V.K.1    Mark, P.B.2    Stewart, G.A.3
  • 77
    • 26444553365 scopus 로고    scopus 로고
    • High incidence of early posttransplantation diabetes mellitus in an eastern population
    • Mohsin N, Budruddin M, Pakkyara A, et al. High incidence of early posttransplantation diabetes mellitus in an eastern population. Transplant Proc 2005; 37: 3093-4
    • (2005) Transplant Proc , vol.37 , pp. 3093-3094
    • Mohsin, N.1    Budruddin, M.2    Pakkyara, A.3
  • 78
    • 0031754125 scopus 로고    scopus 로고
    • Glipizide treatment of post-transplant diabetes does not interfere with cyclosporine pharmacokinetics in renal allograft recipients
    • Sagedal S, Asberg A, Hartmann A, et al. Glipizide treatment of post-transplant diabetes does not interfere with cyclosporine pharmacokinetics in renal allograft recipients. Clin Transplant 1998; 12: 553-6
    • (1998) Clin Transplant , vol.12 , pp. 553-556
    • Sagedal, S.1    Asberg, A.2    Hartmann, A.3
  • 79
    • 29144443855 scopus 로고    scopus 로고
    • Rosiglitazone therapy of posttransplant diabetes mellitus
    • Villanueva G, Baldwin D. Rosiglitazone therapy of posttransplant diabetes mellitus. Transplantation 2005; 80: 1402-5
    • (2005) Transplantation , vol.80 , pp. 1402-1405
    • Villanueva, G.1    Baldwin, D.2
  • 80
    • 20544473128 scopus 로고    scopus 로고
    • Tacrolimus and posttransplant diabetes mellitus in renal transplantation
    • van Hoof JP, Christiaans MH, van Duijnhoven EM. Tacrolimus and posttransplant diabetes mellitus in renal transplantation. Transplantation 2005; 79: 1465-9
    • (2005) Transplantation , vol.79 , pp. 1465-1469
    • Van Hoof, J.P.1    Christiaans, M.H.2    Van Duijnhoven, E.M.3
  • 81
    • 33750529422 scopus 로고    scopus 로고
    • Effect of steroid withdrawal on new onset diabetes after transplant: Results of a randomized double blinded placebo controlled trial
    • [abstract 856] Jul 22-27; Boston
    • Pirsch J, Woodle ES, Shihab F, et al. Effect of steroid withdrawal on new onset diabetes after transplant: results of a randomized double blinded placebo controlled trial [abstract 856]. World Transplant Congress; 2006 Jul 22-27; Boston
    • (2006) World Transplant Congress
    • Pirsch, J.1    Woodle, E.S.2    Shihab, F.3
  • 82
    • 7244245756 scopus 로고    scopus 로고
    • Predictors of success in conversion from calcineurin inhibitor to sirolimus for chronic allograft dysfunction
    • Diekmann F, Budde K, Oppenheimer F, et al. Predictors of success in conversion from calcineurin inhibitor to sirolimus for chronic allograft dysfunction. Am J Transplant 2004; 4: 1869-75
    • (2004) Am J Transplant , vol.4 , pp. 1869-1875
    • Diekmann, F.1    Budde, K.2    Oppenheimer, F.3
  • 83
    • 33644694497 scopus 로고    scopus 로고
    • A randomized controlled trial of late conversion from CNI-based to sirolimus-based immunosuppression following renal transplantation
    • Watson CJ, Firth J, Williams PF, et al. A randomized controlled trial of late conversion from CNI-based to sirolimus-based immunosuppression following renal transplantation. Am J Transplant 2005; 5: 2496-503
    • (2005) Am J Transplant , vol.5 , pp. 2496-2503
    • Watson, C.J.1    Firth, J.2    Williams, P.F.3
  • 84
    • 21644457432 scopus 로고    scopus 로고
    • Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation
    • Oberbauer R, Segoloni G, Campistol JM, et al. Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation. Transpl Int 2005; 18: 22-8
    • (2005) Transpl Int , vol.18 , pp. 22-28
    • Oberbauer, R.1    Segoloni, G.2    Campistol, J.M.3
  • 85
    • 7244247370 scopus 로고    scopus 로고
    • Reduced incidence of new onset diabetes mellitus after renal transplantation with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins)
    • Prasad GV, Kim SJ, Huang M, et al. Reduced incidence of new onset diabetes mellitus after renal transplantation with 3-hydroxy-3-methylglutaryl- coenzyme A reductase inhibitors (statins). Am J Transplant 2004; 4: 1897-903
    • (2004) Am J Transplant , vol.4 , pp. 1897-1903
    • Prasad, G.V.1    Kim, S.J.2    Huang, M.3
  • 86
    • 0037184316 scopus 로고    scopus 로고
    • Kidney transplantation without calcineurin inhibitor drugs: A prospective, randomized trial of sirolimus versus cyclosporine
    • Flechner SM, Goldfarb D, Modlin C, et al. Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine. Transplantation 2002; 74: 1070-6
    • (2002) Transplantation , vol.74 , pp. 1070-1076
    • Flechner, S.M.1    Goldfarb, D.2    Modlin, C.3
  • 87
    • 21044443129 scopus 로고    scopus 로고
    • A calcineurin antagonist-free induction/maintenance strategy for immunosuppression in elderly recipients of renal allografts from elderly cadaver donors: Long-term results from a prospective single centre trial
    • Arbogast H, Huckelheim H, Schneeberger H, et al. A calcineurin antagonist-free induction/maintenance strategy for immunosuppression in elderly recipients of renal allografts from elderly cadaver donors: long-term results from a prospective single centre trial. Clin Transplant 2005; 19: 309-15
    • (2005) Clin Transplant , vol.19 , pp. 309-315
    • Arbogast, H.1    Huckelheim, H.2    Schneeberger, H.3
  • 88
    • 2342596401 scopus 로고    scopus 로고
    • Comparison of sirolimus based calcineurin inhibitor sparing and calcineurin inhibitor-free regimens in cadaveric renal transplantation
    • Lo A, Egidi MF, Gaber LW, et al. Comparison of sirolimus based calcineurin inhibitor sparing and calcineurin inhibitor-free regimens in cadaveric renal transplantation. Transplantation 2004; 77: 1228-35
    • (2004) Transplantation , vol.77 , pp. 1228-1235
    • Lo, A.1    Egidi, M.F.2    Gaber, L.W.3
  • 89
    • 33644678828 scopus 로고    scopus 로고
    • Comparison of sirolimus with low-dose tacrolimus vs sirolimus-based calcineurin inhibitor-free regimen in live donor renal transplantation
    • Hamdy AF, El-Agroudy A, Bakr MA, et al. Comparison of sirolimus with low-dose tacrolimus vs sirolimus-based calcineurin inhibitor-free regimen in live donor renal transplantation. Am J Transplant 2005; 5: 2531-8
    • (2005) Am J Transplant , vol.5 , pp. 2531-2538
    • Hamdy, A.F.1    El-Agroudy, A.2    Bakr, M.A.3
  • 90
    • 0037472871 scopus 로고    scopus 로고
    • Reducing cardiovascular risk in type 2 diabetes
    • Solomon CG. Reducing cardiovascular risk in type 2 diabetes. N Engl J Med 2003; 348: 457-9
    • (2003) N Engl J Med , vol.348 , pp. 457-459
    • Solomon, C.G.1
  • 91
    • 0037034257 scopus 로고    scopus 로고
    • Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
    • Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403
    • (2002) N Engl J Med , vol.346 , pp. 393-403
    • Knowler, W.C.1    Barrett-Connor, E.2    Fowler, S.E.3
  • 92
    • 0032809728 scopus 로고    scopus 로고
    • Patient survival after renal transplantation: II. The impact of smoking
    • Cosio FG, Falkenhain ME, Pesavento TE, et al. Patient survival after renal transplantation: II. The impact of smoking. Clin Transplant 1999; 13: 336-41
    • (1999) Clin Transplant , vol.13 , pp. 336-341
    • Cosio, F.G.1    Falkenhain, M.E.2    Pesavento, T.E.3
  • 93
    • 0037472879 scopus 로고    scopus 로고
    • Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
    • Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348: 383-93
    • (2003) N Engl J Med , vol.348 , pp. 383-393
    • Gaede, P.1    Vedel, P.2    Larsen, N.3
  • 94
    • 33645462551 scopus 로고    scopus 로고
    • Prevention and treatment of diabetic renal disease in type 2 diabetes: The BENEDICT study
    • Remuzzi G, Perico N, Macia M, et al. Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study. J Am Soc Nephrol 2006; 17 Suppl. 2: S90-7
    • (2006) J Am Soc Nephrol , vol.17 , Issue.SUPPL. 2
    • Remuzzi, G.1    Perico, N.2    Macia, M.3
  • 95
    • 0037432304 scopus 로고    scopus 로고
    • Prevention of heart failure in patients in the Heart Outcomes Prevention Evaluation (HOPE) Study
    • Arnold JM, Yusuf S, Young J, et al. Prevention of heart failure in patients in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation 2003; 107: 1284-90
    • (2003) Circulation , vol.107 , pp. 1284-1290
    • Arnold, J.M.1    Yusuf, S.2    Young, J.3
  • 96
    • 30944435875 scopus 로고    scopus 로고
    • Angiotensin II antagonists: Therapeutic benefits spanning the cardiovascular disease continuum from hypertension to heart failure and diabetic nephropathy
    • Ribeirio AB. Angiotensin II antagonists: therapeutic benefits spanning the cardiovascular disease continuum from hypertension to heart failure and diabetic nephropathy. Curr Med Res Opin 2006; 22: 1-16
    • (2006) Curr Med Res Opin , vol.22 , pp. 1-16
    • Ribeirio, A.B.1
  • 97
    • 2942566086 scopus 로고    scopus 로고
    • Outcome at 3 years with a prednisone-free maintenance regimen: A single-center experience with 349 kidney transplant recipients
    • Khwaja K, Asolati M, Harmon JV, et al. Outcome at 3 years with a prednisone-free maintenance regimen: a single-center experience with 349 kidney transplant recipients. Am J Transplant 2004; 4: 980-7
    • (2004) Am J Transplant , vol.4 , pp. 980-987
    • Khwaja, K.1    Asolati, M.2    Harmon, J.V.3
  • 98
    • 31044449097 scopus 로고    scopus 로고
    • Five years of steroid sparing in renal transplantation with tacrolimus and mycophenolate mofetil
    • Borrows R, Chan K, Loucaidou M, et al. Five years of steroid sparing in renal transplantation with tacrolimus and mycophenolate mofetil. Transplantation 2006; 81: 125-8
    • (2006) Transplantation , vol.81 , pp. 125-128
    • Borrows, R.1    Chan, K.2    Loucaidou, M.3
  • 99
    • 27644470998 scopus 로고    scopus 로고
    • Prevention of osteoporotic fractures in the elderly
    • Wilkins CH, Birge SJ. Prevention of osteoporotic fractures in the elderly. Am J Med 2005; 118: 1190-5
    • (2005) Am J Med , vol.118 , pp. 1190-1195
    • Wilkins, C.H.1    Birge, S.J.2
  • 100
    • 0346754948 scopus 로고    scopus 로고
    • Bone mineral density changes within six months of renal transplantation
    • Mikuls TR, Julian BA, Bartolucci A, et al. Bone mineral density changes within six months of renal transplantation. Transplantation 2003; 75: 49-54
    • (2003) Transplantation , vol.75 , pp. 49-54
    • Mikuls, T.R.1    Julian, B.A.2    Bartolucci, A.3
  • 101
  • 102
    • 33748075128 scopus 로고    scopus 로고
    • Effects of bisphosphonates on bone loss in the first year after renal transplantation: A meta-analysis of randomized controlled trials
    • Mitterbauer C, Schwarz C, Haas M, et al. Effects of bisphosphonates on bone loss in the first year after renal transplantation: a meta-analysis of randomized controlled trials. Nephrol Dial Transplant 2006; 21: 2275-81
    • (2006) Nephrol Dial Transplant , vol.21 , pp. 2275-2281
    • Mitterbauer, C.1    Schwarz, C.2    Haas, M.3
  • 103
    • 1342304173 scopus 로고    scopus 로고
    • Lymphomas after solid organ transplantation: A collaborative transplant study report
    • Opelz G, Dohler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant 2004; 4: 222-30
    • (2004) Am J Transplant , vol.4 , pp. 222-230
    • Opelz, G.1    Dohler, B.2
  • 104
    • 28544449370 scopus 로고    scopus 로고
    • Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression
    • Caillard S, Dharnidharka V, Agodoa L, et al. Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression. Transplantation 2005; 80: 1233-43
    • (2005) Transplantation , vol.80 , pp. 1233-1243
    • Caillard, S.1    Dharnidharka, V.2    Agodoa, L.3
  • 105
    • 27644436740 scopus 로고    scopus 로고
    • Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies
    • Kauffman HM, Cherikh WS, Cheng Y, et al. Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies. Transplantation 2005; 80: 883-9
    • (2005) Transplantation , vol.80 , pp. 883-889
    • Kauffman, H.M.1    Cherikh, W.S.2    Cheng, Y.3
  • 106
    • 33645458234 scopus 로고    scopus 로고
    • Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation
    • Campistol JM, Eris J, Oberbauer R. Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation. J Am Soc Nephrol 2006; 17: 581-9
    • (2006) J Am Soc Nephrol , vol.17 , pp. 581-589
    • Campistol, J.M.1    Eris, J.2    Oberbauer, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.